Approximately 96 COVID-19 vaccines are at various stages of clinical development. 1 At
present, we have the interim results of four studies published in scientific journals (on the Pfizer–…

The Ebola virus disease outbreak in West Africa was unprecedented in both its scale and
impact. Out of this human calamity has come renewed attention to global health security—its …

Background Antimicrobial resistance (AMR) poses a major threat to human health around
the world. Previous publications have estimated the effect of AMR on incidence, deaths, …

Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …

Background While it is now apparent clinical sequelae (long COVID) may persist after acute
COVID-19, their nature, frequency and aetiology are poorly characterised. This study aims to …

Objective To characterise the clinical features of children and young people admitted to
hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

There is a lack of effective, safe, and affordable pharmaceuticals to control infectious diseases
that cause high mortality and morbidity among poor people in the developing world. We …

Visceral leishmaniasis is common in less developed countries, with an estimated 500 000
new cases each year. Because of the diversity of epidemiological situations, no single …

Background The long-term sequelae of coronavirus disease 2019 (COVID-19) in children
remain poorly characterised. This study aimed to assess long-term outcomes in children …

WHO recommends a minimum of 80% sensitivity and 97% specificity for antigen-detection
rapid diagnostic tests (Ag-RDTs), which can be used for patients with symptoms consistent …